nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing the cost of cystic fibrosis diagnosis and treatment
|
Rosenberg, Marjorie A. |
|
2005 |
147 |
3S |
p. S101-S105 5 p. |
artikel |
2 |
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions
|
Wilfond, Benjamin S. |
|
2005 |
147 |
3S |
p. S109-S113 5 p. |
artikel |
3 |
Challenges in Implementing a Successful Newborn Cystic Fibrosis Screening Program
|
Comeau, Anne Marie |
|
2005 |
147 |
3S |
p. S89-S93 5 p. |
artikel |
4 |
Communications Systems and their Models: Massachusetts Parent Compliance with Recommended Specialty Care after Positive Cystic Fibrosis Newborn Screening Result
|
Comeau, Anne Marie |
|
2005 |
147 |
3S |
p. S98-S100 3 p. |
artikel |
5 |
Complications associated with symptomatic diagnosis in infants with cystic fibrosis
|
Accurso, Frank J. |
|
2005 |
147 |
3S |
p. S37-S41 5 p. |
artikel |
6 |
Delayed Diagnosis of Cystic Fibrosis and the Family Perspective
|
Kharrazi, Martin |
|
2005 |
147 |
3S |
p. S21-S25 5 p. |
artikel |
7 |
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm
|
Parad, Richard B. |
|
2005 |
147 |
3S |
p. S78-S82 5 p. |
artikel |
8 |
Evidence on Improved Outcomes with Early Diagnosis of Cystic Fibrosis Through Neonatal Screening: Enough is Enough!
|
Farrell, Philip M. |
|
2005 |
147 |
3S |
p. S30-S36 7 p. |
artikel |
9 |
Implementation of Informed Consent for a Cystic Fibrosis Newborn Screening Program in France: Low Refusal Rates for Optional Testing
|
Dhondt, Jean-Louis |
|
2005 |
147 |
3S |
p. S106-S108 3 p. |
artikel |
10 |
Information flow after a positive newborn screening for cystic fibrosis
|
Dillard, James Price |
|
2005 |
147 |
3S |
p. S94-S97 4 p. |
artikel |
11 |
Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment
|
Sims, Erika J. |
|
2005 |
147 |
3S |
p. S42-S46 5 p. |
artikel |
12 |
Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes
|
Campbell III, Preston W. |
|
2005 |
147 |
3S |
p. S2-S5 4 p. |
artikel |
13 |
Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs—Summary Reprinted from the Recommendations and Reports Section of the CDC Publication Morbidity and Mortality Weekly Report, Vol. 53, RR-13, October 15, 2004
|
Centers for Disease Control and Prevention, |
|
2005 |
147 |
3S |
p. S1- 1 p. |
artikel |
14 |
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing
|
Rock, Michael J. |
|
2005 |
147 |
3S |
p. S73-S77 5 p. |
artikel |
15 |
Overview of published evidence on outcomes with early diagnosis from large US observational studies
|
Rosenfeld, Margaret |
|
2005 |
147 |
3S |
p. S11-S14 4 p. |
artikel |
16 |
Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening
|
Koscik, Rebecca L. |
|
2005 |
147 |
3S |
p. S51-S56 6 p. |
artikel |
17 |
Quality of Life of Children with Cystic Fibrosis
|
Koscik, Rebecca L. |
|
2005 |
147 |
3S |
p. S64-S68 5 p. |
artikel |
18 |
Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe
|
Dankert-Roelse, Jeannette E. |
|
2005 |
147 |
3S |
p. S15-S20 6 p. |
artikel |
19 |
Sweat Testing Infants Detected by Cystic Fibrosis Newborn Screening
|
Parad, Richard B. |
|
2005 |
147 |
3S |
p. S69-S72 4 p. |
artikel |
20 |
Talking with parents before newborn screening
|
Clayton, Ellen Wright |
|
2005 |
147 |
3S |
p. S26-S29 4 p. |
artikel |
21 |
The Influence of Newborn Screening for Cystic Fibrosis on Pulmonary Outcomes in New South Wales
|
McKay, Karen O. |
|
2005 |
147 |
3S |
p. S47-S50 4 p. |
artikel |
22 |
The Survival Advantage of Patients with Cystic Fibrosis Diagnosed Through Neonatal Screening: Evidence from the United States Cystic Fibrosis Foundation Registry Data
|
Lai, HuiChuan J. |
|
2005 |
147 |
3S |
p. S57-S63 7 p. |
artikel |
23 |
TOC
|
|
|
2005 |
147 |
3S |
p. A3-A5 nvt p. |
artikel |
24 |
Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes
|
Sontag, Marci K. |
|
2005 |
147 |
3S |
p. S83-S88 6 p. |
artikel |
25 |
Understanding Newborn Screening System Issues With Emphasis on Cystic Fibrosis Screening
|
Therrell, Bradford L. |
|
2005 |
147 |
3S |
p. S6-S10 5 p. |
artikel |